The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
Open accessAbstract
Animal models link ectopic lipid accumulation to renal dysfunction, but whether this process occurs in the human kidney is uncertain. To this end, we investigated whether altered renal TG and cholesterol metabolism results in lipid accumulation in human diabetic nephropathy (DN). Lipid staining and the expression of lipid metabolism genes were studied in kidney biopsies of patients with diagnosed DN (n = 34), and compared with normal kidneys (n = 12). We observed heavy lipid deposition and increased intracellular lipid droplets. Lipid deposition was associated with dysregulation of lipid metabolism genes. Fatty acid β-oxidation pathways including PPAR-α, carnitine palmitoyltransferase 1, acyl-CoA oxidase, and L-FABP were downregulated. Downregulation of renal lipoprotein lipase, which hydrolyzes circulating TGs, was associated with increased expression of angiopoietin-like protein 4. Cholesterol uptake receptor expression, including LDL receptors, oxidized LDL receptors, and acetylated LDL receptors, was significantly increased, while there was downregulation of genes effecting cholesterol efflux, including ABCA1, ABCG1, and apoE. There was a highly significant correlation between glomerular filtration rate, inflammation, and lipid metabolism genes, supporting a possible role of abnormal lipid metabolism in the pathogenesis of DN. These data suggest that renal lipid metabolism may serve as a target for specific therapies aimed at slowing the progression of glomerulosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Pathologic Classification of Diabetic Nephropathy
Tervaert, T. W. C., Mooyaart, A. L., Amann, K., Cohen, A. H., Cook, H. T., Drachenberg, C. B., Ferrario, F., Fogo, A. B., Haas, M., de Heer, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010010 · Cited by 1,690
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart
Sharma, S., Adrogue, J. V., Golfman, L., Uray, I., Lemm, J., Youker, K., Noon, G. P., Frazier, O. H., & Taegtmeyer, H. (2004) · The FASEB Journal · doi:10.1096/fj.04-2263com · Cited by 790
Biochemical and physiological function of stearoyl-CoA desaturase
Paton, C. M., & Ntambi, J. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90897.2008 · Cited by 741
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Benhamed, F., Denechaud, P.-D., Lemoine, M., Robichon, C., Moldes, M., Bertrand-Michel, J., Ratziu, V., Serfaty, L., Housset, C., Capeau, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci41636 · Cited by 408
Renal lipid metabolism and lipotoxicity
Bobulescu, I. A. (2010) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32833aa4ac · Cited by 364
Sun, L., Halaihel, N., Zhang, W., Rogers, T., & Levi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110650200 · Cited by 333
Self-citationClement, L. C., Avila-Casado, C., Macé, C., Soria, E., Bakker, W. W., Kersten, S., & Chugh, S. S. (2011) · Nature Medicine · doi:10.1038/nm.2261 · Cited by 331
Proctor, G., Jiang, T., Iwahashi, M., Wang, Z., Li, J., & Levi, M. (2006) · Diabetes · doi:10.2337/db05-0603 · Cited by 303
Self-citationWang, Z., Jiang, T., Li, J., Proctor, G., McManaman, J. L., Lucia, S., Chua, S., & Levi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2328 · Cited by 303
Self-citationFarnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Jiang, T., Wang, X. X., Scherzer, P., Wilson, P., Tallman, J., Takahashi, H., Li, J., Iwahashi, M., Sutherland, E., Arend, L., et al. (2007) · Diabetes · doi:10.2337/db06-1642 · Cited by 236
Self-citationInflammation stimulates the expression of PCSK9
Feingold, K. R., Moser, A. H., Shigenaga, J. K., Patzek, S. M., & Grunfeld, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.023 · Cited by 228
Wang, X. X., Jiang, T., Shen, Y., Caldas, Y., Miyazaki-Anzai, S., Santamaria, H., Urbanek, C., Solis, N., Scherzer, P., Lewis, L., et al. (2010) · Diabetes · doi:10.2337/db10-0019 · Cited by 186
Self-citationWang, X. X., Jiang, T., Shen, Y., Adorini, L., Pruzanski, M., Gonzalez, F. J., Scherzer, P., Lewis, L., Miyazaki-Anzai, S., & Levi, M. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00404.2009 · Cited by 178
Self-citationRole of triglyceride-rich lipoproteins in diabetic nephropathy
Rutledge, J. C., Ng, K. F., Aung, H. H., & Wilson, D. W. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.59 · Cited by 159
Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome
Marfella, R., Filippo, C. D., Portoghese, M., Barbieri, M., Ferraraccio, F., Siniscalchi, M., Cacciapuoti, F., Rossi, F., D’Amico, M., & Paolisso, G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900032-jlr200 · Cited by 151
Kim, H. J., Moradi, H., Yuan, J. J., Norris, K. C., & Vaziri, N. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90761.2008 · Cited by 123
Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya, T., Tanaka, N., Suzuki, T., Sano, K., Horiuchi, A., Komatsu, M., Nakajima, T., Nishizawa, T., Joshita, S., Umemura, T., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.033 · Cited by 120
LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney
Feingold, K. R., Wang, Y., Moser, A. H., Shigenaga, J. K., & Grünfeld, C. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800233-jlr200 · Cited by 119
Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β
Herman‐Edelstein, M., Thomas, M. C., Thallas‐Bonke, V., Saleem, M. A., Cooper, M. E., & Kantharidis, P. (2011) · Diabetes · doi:10.2337/db10-1110 · Cited by 117
Self-citationNosadini, R., & Tonolo, G. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.002 · Cited by 109
Gutwein, P., Abdel‐Bakky, M. S., Schramme, A., Doberstein, K., Kämpfer‐Kolb, N., Amann, K., Hauser, I. A., Obermüller, N., Bartel, C., Abdel‐Aziz, A. H., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080960 · Cited by 91
Myocardial triacylglycerol metabolism
Kienesberger, P. C., Pulinilkunnil, T., Nagendran, J., & Dyck, J. R. B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.06.018 · Cited by 88
Wang, Y., Moser, A. H., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500134-jlr200 · Cited by 82
Mishra, R., Emancipator, S. N., Miller, C. M., Kern, T. S., & Simonson, M. S. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00323.2003 · Cited by 82
Dobrzyń, P., Sampath, H., Dobrzyń, A., Miyazaki, M., & Ntambi, J. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2007 · Cited by 81
Soler, M. J., Riera, M., & BATLLE, D. C. (2012) · Experimental Diabetes Research · doi:10.1155/2012/616313 · Cited by 79
Martini, S., Eichinger, F. H., Nair, V., & Kretzler, M. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9103-3 · Cited by 76
Myocardial lipid accumulation and lipotoxicity in heart failure
Schulze, P. C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r001115 · Cited by 70
CXCL16 and oxLDL are induced in the onset of diabetic nephropathy
Gutwein, P., Abdel‐Bakky, M. S., Doberstein, K., Schramme, A., Beckmann, J., Schaefer, L., Amann, K., Doller, A., Kämpfer‐Kolb, N., Abdel‐Aziz, A. H., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00761.x · Cited by 70
Chou, K.-M., Lee, C., Chen, C.-H., & Sun, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054863 · Cited by 67
Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm
Feingold, K. R., Moser, A., Patzek, S. M., Shigenaga, J. K., & Grunfeld, C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800655-jlr200 · Cited by 59
Rogowski, M. P., Flowers, M. T., Stamatikos, A., Ntambi, J. M., & Paton, C. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035865 · Cited by 57
Activation of Liver X Receptor Inhibits Osteopontin and Ameliorates Diabetic Nephropathy
Tachibana, H., Ogawa, D., Matsushita, Y., Bruemmer, D., Wada, J., Teshigawara, S., Eguchi, J., Horiguchi, C. S., Uchida, H. A., Shikata, K., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010022 · Cited by 54
Fibrates: Therapeutic potential for diabetic nephropathy?
Kouroumichakis, I., Παπάνας, Ν., Zarogoulidis, P., Liakopoulos, V., Maltezos, E. S., & Mikhailidis, D. P. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.12.007 · Cited by 43
Kamanna, V. S., Roh, D. D., & Kirschenbaum, M. A. (1998) · PubMed · doi:10.14670/hh-13.169 · Cited by 40
Li, S., Nagothu, K. K., Ranganathan, G., Ali, S. M., Shank, B. B., Gökden, N., Ayyadevara, S., Megyesi, J. K., Olivecrona, G., Chugh, S. S., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00111.2012 · Cited by 37
Mayrhofer, C., Krieger, S., Huttary, N., Chang, M. W.-F., Grillari, J., Allmaier, G. M., & Kerjaschki, D. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080654 · Cited by 36
Kim, M. S., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grünfeld, C. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500217-jlr200 · Cited by 36
Lipid Droplet-Associated Proteins Protect Renal Tubular Cells from Fatty Acid-Induced Apoptosis
Urahama, Y., Ohsaki, Y., Fujita, Y., Maruyama, S., Yuzawa, Y., Matsuo, S., & Fujimoto, T. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080137 · Cited by 33
Lipids and diabetic renal disease
Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0053-9 · Cited by 23
Suppression of Chronic Damage in Renal Allografts by Liver X Receptor (LXR) Activation
Kiss, É., Popovic, Z., Bedke, J., Wang, S., Bonrouhi, M., Gretz, N., Stettner, P., Teupser, D., Thiery, J., Porubský, Š., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.019 · Cited by 22
Nuclear Hormone Receptors as Therapeutic Targets
Levi, M., Wang, X., & Choudhury, D. (2011) · Contributions to nephrology · doi:10.1159/000325668 · Cited by 21
Self-citationAngiopoietin like protein 4 expression is decreased in activated macrophages
Feingold, K. R., Shigenaga, J. K., Cross, A. S., Moser, A. H., & Grünfeld, C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.055 · Cited by 21
Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats
Muroya, Y., Ito, O., Rong, R., Takashima, K., Ito, D., Cao, P., Nakamura, Y., Joh, K., & Kohzuki, M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00365.2011 · Cited by 20
Intraglomerular lipid deposition in renal disease.
Lee, H. S., & Lee, S. K. (1993) · PubMed · Cited by 9
Improvement of myocardial lipid accumulation and prevention of PGC-1α induction by fenofibrate
Zang, M. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.841 · Cited by 5
Cited by
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Self-citationMitochondrial dysfunction in diabetic kidney disease
Forbes, J. M., & Thorburn, D. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.9 · Cited by 634
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
DeFronzo, R. A., Reeves, W. B., & Awad, A. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00393-8 · Cited by 589
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
Metadata
- Authors
- Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M., & Gafter, U.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 55
- Issue
- 3
- Pages
- 561-572
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2094077779
- Cited by
- 645
- References
- 48
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.